Format

Send to

Choose Destination
Headache. 2019 Jul;59 Suppl 2:33-49. doi: 10.1111/head.13586.

Neuromodulation for the Acute and Preventive Therapy of Migraine and Cluster Headache.

Author information

1
Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
2
Department of Neurology, Georgetown University, Washington, DC, USA.
3
Department of Neurology, Weill Cornell Medicine, New York, NY, USA.

Abstract

Headache disorders are among the most common and disabling medical conditions worldwide. Pharmacologic acute and preventive treatments are often insufficient and poorly tolerated, and the majority of patients are unable to adhere to their migraine treatments due to these issues. With improvements in our understanding of migraine and cluster headache pathophysiology, neuromodulation devices have been developed as safe and effective acute and preventive treatment options. In this review, we focus on neuromodulation devices that have been studied for migraine and cluster headache, with special attention to those that have gained food and drug administration (FDA) clearance. We will also explore how these devices can be used in patients who might have limited pharmacologic options, including the elderly, children, and pregnant women.

KEYWORDS:

cluster headache; migraine acute treatment; migraine prevention; neuromodulation; neurostimulation

PMID:
31291017
DOI:
10.1111/head.13586

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center